Expression of somatostatin receptor subtypes and growth inhibition in human exocrine pancreatic cancers

Journal of Hepato-Biliary-Pancreatic Surgery

Volumn 7, Issue 5, 2000, Pages 496-503

  Kikutsuji, Toru ^a,b   Harada, Masamitsu ^a   Tashiro, Seiki ^a   Setsuko, Ii ^a   Moritani, Maki ^a   Yamaoka, Takashi ^a   Itakura, Mitsuo ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b National Kochi Hospital   (Japan)

Author keywords

Octreotide; Pancreatic cancer; Somatostatin; sstr

Indexed keywords

DRUG DERIVATIVE; OCTREOTIDE; SOMATOSTATIN; SOMATOSTATIN RECEPTOR; VAPREOTIDE;

ARTICLE; CELL CULTURE; CELL DIVISION; CLASSIFICATION; DRUG EFFECT; GENETICS; HUMAN; METABOLISM; PANCREAS TUMOR; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

CELL DIVISION; HUMANS; OCTREOTIDE; PANCREATIC NEOPLASMS; RECEPTORS, SOMATOSTATIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SOMATOSTATIN; TUMOR CELLS, CULTURED;

EID: 0034569570     PISSN: 09441166     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005340070021     Document Type: Article

References (37)

1. Ohashi O, Yamamoto M, Ishida H, Fujiwara H, Hasegawa Y, Saitoh Y (1997) The results of treatment for pancreatic cancer -statistic change (in Japanese with English abstract). Nippon Geka Gakkai Zasshi (J Jpn Surg Soc) 98:588-591
2. Johnson LR (1981) Effects of gastrointestinal hormones on pancreatic growth. Cancer 47:1640-1645
3. Liebow C, Reilly C, Serrano M, Schally AV (1989) Somatostatin analogues inhibit growth of pancreatic cancer by stimulating tyrosine phosphatase. Proc Natl Acad Sci USA 86:2003-2007
4. Yamada Y, Post SR, Wang K, Tager HS, Bell GI, Seino S (1992) Cloning and functional characterization of a family of human and mouse somatostatin receptors expressed in brain, gastrointestinal tract and kidney. Proc Natl Acad Sci USA 89:251-255
5. Bruno JF, Xu Y, Song J, Berelowitz M (1992) Molecular cloning and functional expression of a brain-specific somatostatin receptor. Proc Natl Acad Sci USA 89:11151-11155
6. O'Carroll AM, Lolait SJ, König M, Mahan LC (1992) Molecular cloning and expression of a pituitary somatostatin receptor with preferential affinity for somatostatin-28. Mol Pharmacol 42:939-946
7. Hoyer D, Lübbert H, Bruns C (1994) Molecular pharmacology of somatostatin receptors. Naunyn Schmiedebergs Arch Pharmacol 350:441-453
8. Patel YC, Srikant CB (1994) Subtype selectivity of peptide analogs for all five cloned human somatostatin receptors (hsstr 1-5). Endocrinology 135:2814-2817
9. Hofland LJ, Visser-Wisselaar HA, Lamberts SWJ (1995) Somatostatin analogs: clinical application in relation to human somatostatin receptor subtypes. Biochem Pharmacol 50:287-297
10. Reubi JC (1996) Octreotide and nonendocrine tumros: basic knowledge and therapeutic potential. Prog Basic Clin Pharmacol 10:246-269
11. Law SF, Woulfe D, Reisine T (1995) Somatostatin receptor activation of cellular effector systems. Cell Signal 7:1-8
12. Buscail L, Delesque N, Estève J-P, Saint-Laurent N, Prats H, Clerc P, Robberecht P, Bell GL, Liebow C, Shally AV, Vaysse N, Susini C (1994) Stimulation of tyrosine phosphatase and inhibition of cell proliferation by somatostatin analogues: mediation by human somatostatin receptor subtypes SSTR1 and SSTR2. Proc Natl Acad Sci USA 91:2315-2319
13. Paz-Bouza JI, Reddin TW, Schally AV (1987) Treatment of nitrosamine-induced pancreatic tumors in hamsters with analogs of somatostatin and luteinizing hormone-releasing hormone. Proc Natl Acad Sci USA 84:1112-1116
14. Zalatnai A, Schally AV (1989) Responsiveness of hamster pancreatic cancer to treatment with microcapsules of D-Trp-6-LH-RH and somatostatin analog RC-160: histological evidence of improvement. Int J Pancreatol 4:149-160
15. Schally AV (1988) Oncological applications of somatostatin analogues. Cancer Res 48:6977-6985
16. Sambrook J, Fritsch EF, Maniatis T (1989) Isolation of DNA fragment from polyacrylamide gels. In: Ford N, Nolan C, Ferguson M (eds) Molecular cloning: a laboratory manual, second edition: Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, pp 6.46-6.48
17. Vanetti M, Kouba M, Wang X, Vogt G, Hollt V (1992) Cloning and expression of a novel mouse somatostatin receptor (SSTR2B). FEBS Lett 311:290-294
18. Patel YC, Greenwood MT, Warszynska A, Panetta R, Srikant CB (1994) All five cloned human somatostatin receptors (hsstrl-5) are functionally coupled to adenylyl cyclase. Biochem Biophys Res Commun 198:605-612
19. Karasuyama H, Melchers F (1988) Establishment of mouse cell lines which constitutivcly secrete large quantities of interleukin 2, 3, 4 or 5, using modified cDNA expression vectors. Eur J Immunol 18:97-104
20. 5 Pre-B cell-specific genes can associate with each other and with μ heavy chain. J Exp Med 172:969-972
21. Carmichael J, DeGraff WG, Gazdar AF, Minna JD, Mitchell JB (1987) Evaluation of a tetrazolium-basce semiautomated colorimetric assay: assessment of chemosensitivity testing. Cancer Res 47:936-942
22. Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65:55-63
23. Buscail L, Saint-Laurent N, Chastre E, Vaillant JC, Gespach C, Capellà G, Kalthoff H, Lluis F, Vaysse N, Susini C (1996) Loss of sst2 somatostatin receptor gene expression in human pancreatic and colorectal cancer. Cancer Res 56:1823-1827
24. Reubi JC, Horisberger U, Essed CE, Jeekel J, Klijn JGH, Lamberts SWJ (1988) Absence of somatostatin receptors in human exocrine pancreatic adenocarcinomas. Gastroenterology 95:760-763
25. Ain KB, Taylor KD, Tofiq S, Venkataraman G (1997) Somatostatin receptor subtype expression in human thyroid and thyroid carcinoma cell lines. J Clin Endocrinol Metab 82:1857-1862
26. Barton CM, Hall PA, Hughes CM, Gullick WJ, Lemoine NR (1991) Transforming growth factor-alpha and epidermal growth factor in human pancreatic cancer. J Pathol 163:111-116
27. Lemoine NR, Hughes CM, Barton CM, Poulsom R, Jeffery RE, Klöppel G, Hall PA, Gullick WJ (1992) The epidermal growth factor receptor in human pancreatic cancer. J Pathol 166:7-12
28. Vidal C, Rauly I, Zeggari M, Delesque N, Esteve JP, Saint-Laurent N, Vaysse N, Susini C (1994) Up-regulation of somatostatin receptors by epidermal growth factor and gastrin in pancreatic cancer cells. Mol Pharmacol 45:97-104
29. Klijn JGM, Hoff AM, Planting ASTh, Verweij J, Kok T, Lamberts SWJ, Portengen H, Foekens JA (1990) Treatment of patients with mctastatic pancreatic and gastrointestinal tumors with the somatostatin analogue Sandostatin: a phase II study including endocrine effects. Br J Cancer 62:627-630
30. Canobbio L, Boccardo F, Cannata D, Gallotti P, Epis R (1992) Treatment of advanced pancreatic carcinoma with the somatostatin analogue BIM 23014. Cancer 69:648-650
31. Friess H, Büchler M, Beglinger C, Weber A, Kunz J, Fritsch K, Dennler HJ, Beger HG (1993) Low-dose octreotidc treatment is not effective in patients with advanced pancreatic cancer. Pancreas 8:540-545
32. Raderer M, Hamilton G, Kurtaran A, Valencak J, Haberl I, Hoffmann O, Kornek GV, Vorbeck F, Hejna MHL, Virgolini I, Scheithauer W (1999) Treatment of advanced pancreatic cancer with the long-acting somatostain analogue lanreotide: in vitro and in vivo results. Br J Cancer 79:535-537
33. Buscail L, Estève JP, Saint-Laurent N, Bertrand V, Reisine T, O'Carroll AM, Bell GI, Shally AV, Vaysse N, Susini C (1995) Inhibition of cell proliferation by the somatostatin analogue RC-160 is mediated by somatostatin receptor subtypes SSTR2 and SSTR5 through different mechanisms. Proc Natl Acad Sci USA 92:1580-1584
34. Frieß H, Büchler M, Ebert M, Malfertheiner P, Dennler HJ, Beger HG (1993) Treatment of advanced pancreatic cancer with high-dose octreotide. Int J Pancreatol 14:290-291
35. Froidevaux S, Hintermann E, Török M, Mäcke HR, Beglinger C, Eberle AN (1999) Differential regulation of somatostatin receptor type 2 (sst2) expression in AR4-2J tumor cells implanted into mice during octreotide treatment. Cancer Res 59:3652-3657
36. Fisher WE, Doran TA, Muscarella II P, Boros LG, Ellison C, Schirmer WJ (1998) Expression of somatostatin receptor subtype 1-5 genes in human pancreatic cancer. J Natl Cancer Inst 90:322-324
37. Delesque N, Buscail L, Esteve JP, Saint-Laurent N, Müllier C, Weckbecker G, Bruns C, Vaysse N, Susini C (1997) sst2 somatostatin receptor expression reverses tumorigenicity of human pancreatic cancer cells. Cancer Res 57:956-962